Neuroprotection of fullerene in improving cognitive-behavioral disruptions and neurobiochemical enzymes activities

Nanomedicine (Lond). 2023 Mar;18(6):525-539. doi: 10.2217/nnm-2023-0007. Epub 2023 May 17.

Abstract

Aim: Here, we report the synthesis and evaluation of fullerene C60 nanoparticles' (FC60 NPs) therapeutic efficacy in animals with aluminum-induced oxidative stress. Materials & methods: Effects of FC60 NPs on the altered activity levels of neurobiochemical enzymes and oxidative parameters in brain and liver tissues have been evaluated. Aluminum was injected for 3 weeks and from the beginning of the third week, FC60 NPs were injected for 1 week. Results: Administration of FC60 NPs showed a significant improvement in the altered activity level of the selected markers. Conclusion: Results suggest synthesized FC60 NPs as a therapeutic option for the treatment of neurodegenerative diseases.

Keywords: aluminum; fullerene; neuroprotection; oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aluminum / pharmacology
  • Animals
  • Cognition
  • Fullerenes* / pharmacology
  • Fullerenes* / therapeutic use
  • Neuroprotection
  • Oxidative Stress

Substances

  • fullerene C60
  • Fullerenes
  • Aluminum